JPRN-UMIN000044180招募中未知
Efficacy of brolucizumab on AMD in patients exhibiting aflibercept resistance - AMD treated by anti-VEGF drugs
agoya University0 个研究点目标入组 50 人开始时间: 2021年5月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •nothing special
研究者
相似试验
招募中
不适用
The effect of brolucizumab on age-related macular degeneratioAge-related macular degenerationJPRN-UMIN000044356Department of Ophthalmology, Juntendo University Faculty of Medicine50
招募中
不适用
Treatment with aflibercept for AMD cases with better value in optometryage-related macular degenerationJPRN-UMIN000012221Keio University, School of Medicine30
招募中
3 期
Adalimumab effect on COVID-19IRCT20171105037262N4Bagheiat-allah University of Medical Sciences100
已完成
不适用
Clinical Effectiveness of Adalimumab (Exemptiaâ?¢) in patients suffering from symptomatic Ankylosing Spondylitis (AS) under supervised standard rheumatology careCTRI/2018/02/012018CENTER FOR RHEUMATIC DISEASES50
尚未招募
2 期
The effect of Adalimumab in the treatment of patients with chronic schizophreniaSchizophrenia.SchizophreniaIRCT20090117001556N126Tehran University of Medical Sciences50